The intra-aortic balloon (IAB) is an minimally invasive technology designed to enhance blood flow to the heart and other ...
Hemodynamic Support Devices
This hemodynamic support systems channel includes content on intra-aortic balloon pumps (IABP), percutaneous ventricular assist devices (pVAD) like the Impella or TandemHeart, extracorporeal membrane oxygenation (ECMO), and ventricular assist devices (VAD). This channel also includes use of these devices in support of patients in cardiogenic shock and advanced heart failure.
Feb. 23, 2007 — Dr. William T Abraham of Ohio State University, Columbus, Ohio and Dr. Patrick M McCarthy of ...
Feb. 23, 2007 — West Virginia holds the dubious rank of the state with the highest percentage of residents with heart ...
Jan. 25, 2007 — Abiomed, Inc. has announced the development of a pediatric circulatory support technology. Currently in ...
AP reports that a Dec. 27 Medicare proposal may could double the number of hospitals authorized to implant the HeartMate ...
The British Standards Institute has given CE Marking to Ventracor for its VentrAssist left ventricular assist device ...
The FDA medical devices dispute resolution panel that met on Dec. 15 voted 3 to 1 to uphold a previous FDA decision that ...
Two Illinois medical centers are now ready to use the TandemHeart PTVA System from CardiacAssist: Northwestern Memorial ...
MicroMed Cardiovascular, Inc. has received a CE Mark extension to continue marketing its DeBakey VAD system in Europe ...
The FDA will convene a Medical Device Dispute Resolution Panel (MDDRP) on Dec. 15 to consider the first device to ...
If its cancer care, emergency medicine, pediatric and maternal-fetal medicine specialties keep Robert Wood Johnson ...
Abiomed Inc. recently announced the start of the IMPELLA 2.5 pilot study in the U.S. with the enrollment of the first ...
The EXCOR TAH-t has received CE approval with the CardioWest TAH-t. The pneumatic drivers provide precisely calibrated ...
At a pivotal time of advancement in cardiovascular imaging, diagnostics, interventions and therapies, a time when ...
ABIOMED Inc. is commencing its pilot clinical trial in the U.S. for the IMPELLA 2.5 minimally invasive ventricular ...